mRNA |
SCH-79797 |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.03 |
mRNA |
MLN2480 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.03 |
mRNA |
ML258 |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.03 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.03 |
mRNA |
IPR-456 |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.03 |
mRNA |
AT7867 |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.03 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.03 |
mRNA |
ML210 |
CTRPv2 |
pan-cancer |
AAC |
-0.073 |
0.03 |
mRNA |
LY-2183240 |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.03 |
mRNA |
COL-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.03 |